IUS Publications

Found 11 results
Filters: Author is Hromić-Jahjefendić, Altijana  [Clear All Filters]
2024
S. Hossein Shahcheraghi, Alimardani, M., Lotfi, M., Lotfi, M., Uversky, V. N., Guetchueng, S. Tamdem, Palakurthi, S. Shrivastsa, Charbe, N. B., Hromić-Jahjefendić, A., Aljabali, A. A. A., Gadewar, M. M., Malik, S., Goyal, R., El-Tanani, M., Mishra, V., Mishra, Y., and Tambuwala, M. M., “Advances in Glioblastoma Multiforme: Integrating Therapy and Pathology Perspectives”, Pathology - Research and Practice, p. 155285, 2024.
M. Golzardi, Hromić-Jahjefendić, A., Sutkovic, J., Aydın, O., Ünal-Aydın, P., Bećirević, T., Redwan, E. M., Rubio-Casillas, A., and Uversky, V. N., “The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems”, Biomedicines, vol. 12, no. 4, p. 913, 2024.
A. Hromić-Jahjefendić, Lundstrom, K., Adilović, M., Aljabali, A. A. A., Tambuwala, M. M., Serrano-Aroca, Á., and Uversky, V. N., “Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines”, Autoimmunity Reviews, vol. 23, no. 3, p. 103508, 2024.
M. El-Tanani, Nsairat, H., Matalka, I. I., Lee, Y. Fai, Rizzo, M., Aljabali, A. A., Mishra, V., Mishra, Y., Hromić-Jahjefendić, A., and Tambuwala, M. M., “The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia”, Pathology - Research and Practice, p. 155161, 2024.
S. Hossein Shahcheraghi, Asl, E. Roshani, Lotfi, M., Ayatollahi, J., Khaleghinejad, S. Hossein, Aljabali, A. A., Bakshi, H. A., El-Tanani, M., Charbe, N., Serrano-Aroca, Á., Mishra, V., Mishra, Y., Goyal, R., Hromić-Jahjefendić, A., Uversky, V. N., Lotfi, M., and Tambuwala, M. M., “Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic TargetsAbstract:”, CNS & Neurological Disorders - Drug Targets, vol. 23, 2024.
Y. Mishra, Ranjan, A., Mishra, V., Chattaraj, A., Aljabali, A. A. A., El-Tanani, M., Hromić-Jahjefendić, A., Uversky, V. N., and Tambuwala, M. M., “The role of the gut microbiome in gastrointestinal cancers”, Cellular Signalling, vol. 115, p. 111013, 2024.
S. Sarif Hassan, Bhattacharya, T., Nawn, D., Jha, I., Basu, P., Redwan, E. M., Lundstrom, K., Barh, D., Andrade, B. Silva, Tambuwala, M. M., Aljabali, A. A., Hromić-Jahjefendić, A., Baetas-da-Cruz, W., Serrano-Aroca, Á., and Uversky, V. N., “SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants”, Computers in Biology and Medicine, vol. 170, p. 107899, 2024.
2023
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutović, L., Sezer, A., Roca, S., Špirtović-Halilović, S., Salihović, M., Hromić-Jahjefendić, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, vol. 96, no. 1, pp. 59 - 68, 2023.
A. Hromić-Jahjefendić, Sezer, A., Aljabali, A. A. A., Serrano-Aroca, Á., Tambuwala, M. M., Uversky, V. N., Redwan, E. M., Barh, D., and Lundstrom, K., “COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence”, Biomedicines, vol. 11, no. 5, p. 1469, 2023.
2022
E. Bilajac, Mahmutović, L., Lundstrom, K., Glamočlija, U., Sutkovic, J., Sezer, A., and Hromić-Jahjefendić, A., “Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis”, Viruses, vol. 14, no. 10, p. 2105, 2022.
2021
A. Hromić-Jahjefendić, Ler, D., Međedović, D., Tahirović, E., Karamehmedović, E., Karađuzović-Hadžiabdić, K., Suljagić, M., Hadžiabdić, M., Rabiei, N., Palalic, R., and Durakovic, B., Master studies in Bioanalitical technologies : instructions for lecturers. Internacionalni univerzitet u Sarajevu, 2021.